FDA Approves Tecentriq for First-Line ... - Lung Cancer Support

Lung Cancer Support

3,317 members1,782 posts

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

Miranda_GO2
Miranda_GO2Administrator

On May 18th, 2020, the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) for the first line treatment of advanced non-small cell lung cancer (NSCLC) with tumors having high expressions of PD-L1 (>50%) and no changes in EGFR or ALK. The FDA based their approval on the results of the clinical trial IMpower-110 which showed that patients receiving Tecentriq (atezolizumab) lived longer, had a higher chance of responding well to treatment, and went longer periods of time without progression than those receiving chemotherapy.

Tecentriq (atezolizumab) being available as a first line immunotherapy option for NSCLC gives patients more options for first line treatments than ever before.

Read the full release here: fda.gov/drugs/resources-inf...

10 Replies
oldestnewest
Denzie
DenzieModerator

Thanks Miranda! This is the 4th treatment approval in 2 weeks. I can’t remember another time in lung cancer advocacy like this. Amazing. Just amazing.

Miranda_GO2
Miranda_GO2Administrator in reply to Denzie

It's incredible. Jennifer King (GO2's Chief Science Officer) is writing a blog about all the approvals this week. Despite COVID-19, new approvals are being made. Very thankful for that! I'm be sure to share the blog post by Jennifer once it's done!

Been on this drug for over a year but have progression and off of it for now. Just wanted to let those interested in it that I found it to be a very easy drug to handle with mild to no side effects.

Miranda_GO2
Miranda_GO2Administrator in reply to Seaspray298

Thanks for sharing that with the community. Sorry to hear of your progression, do you and your doctor talk about your next treatment line options?

I will be having radiation to 2-3 areas starting tomorrow. Dr. spoke of possibly going back on Tecentriq when radiation treatments are completed. I have the KRAS mutation so am anxiously waiting for the new drug that is in trials right now.

Miranda_GO2
Miranda_GO2Administrator in reply to Seaspray298

Yes, I am also eagerly looking toward that trial information. Do you know what KRAS mutation you have? Are you part of the peer group for KRAS?

I have the KRAS G12C mutation. I do not know of any peer groups for KRAS.

Miranda_GO2
Miranda_GO2Administrator in reply to Seaspray298

Well, I hope one day we can post about a KRAS approval!

Are you part of the lung cancer registry? If you aren't, please join: healthunlocked.com/api/redi...

The KRAS group is a new group that was started by a patient recently. Here is the link to the page she created: kraskickers.org/. She also has a facebook group. It's not a GO2 group, but I love to connect patients (hints my role as the Phone Buddy manager at GO2) and Terri who started the group is a great person to connect with! I'm sure she would love to meet you (virtually, of course)!

Denzie
DenzieModerator in reply to Seaspray298

Can your doctor get you expanded access for the trial drug or can you get enrolled in the actual trial? And I second everything Miranda said about the KRASkickers group.

Seaspray298
Seaspray298 in reply to Denzie

My doctor says she hopes to have the trial at Mayo in the Fall. The closest trial to me is 2 hours away which I am not able to do by myself. Today begins my radiation treatments for 10 sessions. Looking forward to getting out of pain!

You may also like...